| Financial Year |
March 31 2023 |
| Monetary Funds |
5,051,738,376.99 |
| Held-for-trading Financial Assets |
638,997,223.93 |
| Notes Receivable |
426,932,672.74 |
| Accounts Receivable |
11,800,579,687.66 |
| Advances to Suppliers |
839,417,798.50 |
| Other Receivables |
3,692,204,759.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,934,516,528.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
516,807,008.33 |
| Total Current Assets |
28,797,871,251.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
204,392,208.47 |
| Investment Properties |
-- |
| Fixed Assetes |
8,725,716,727.37 |
| Under-construction Projects |
2,265,037,490.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,112,332,349.74 |
| R&D expenses |
-- |
| Goodwill |
150,279,890.81 |
| Long-Term Deferred and Prepaid Expenses |
74,563,245.28 |
| Deferred Income Tax Assets |
678,258,246.28 |
| Other Non-Current Assets |
2,126,962,710.64 |
| Sub-Total of Non-Current Assets |
18,515,440,898.11 |
| Total Assets |
47,313,312,149.23 |
| Short-Term Loans |
4,167,174,892.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
611,820,365.77 |
| Accounts Payable |
3,486,936,125.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
93,128,748.38 |
| Taxes Payable |
561,022,335.24 |
| Interest Payable |
-- |
| Dividend Payable |
39,800.00 |
| Other payables |
5,223,059,492.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
526,842,272.25 |
| Other Current Liabilities |
321,230,904.51 |
| Sub-Total of Current Liabilities |
17,575,114,722.30 |
| Long-term Loans |
1,333,716,319.45 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
53,882,911.11 |
| Special Payable |
-- |
| Estimatied Liabilities |
38,653,133.19 |
| Deferred Income Tax Liabilities |
10,532,512.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,175,021,870.17 |
| Total Liabilities |
19,750,136,592.47 |
| Paid-In Capital(Or Share Stock) |
2,518,464,191.00 |
| Capital Surplus |
10,701,710,682.62 |
| Surplus Reserve |
543,827,204.85 |
| LESS:Treasury Stock |
1,121,608,787.15 |
| Undistributed Profits |
14,506,487,075.43 |
| Minority Stockholder's Interest |
388,703,842.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
27,174,471,714.10 |
| Owner's Equity（Stockholder's Equity） |
27,563,175,556.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
47,313,312,149.23 |
